McIlrath & Eck’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

McIlrath & Eck’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,773	Closed	-$133	–	979
2022 Q4	$133	Hold	1,773	–	–	﹤0.01%	861
2022 Q3	$2K	Hold	1,773	–	–	﹤0.01%	784
2022 Q2	$3K	Buy	+1,773	New	+$8.15K	﹤0.01%	714

Other funds holding CORZ

SFS

Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return

CWC

Carolinas Wealth Consulting Charlotte, North Carolina $465M AUM 8.53% 1-Year Est. Return

BWP

BSW Wealth Partners Boulder, Colorado $899M AUM 28.56% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

McIlrath & Eck's CORZ Position: Q1 2023 in Review

McIlrath & Eck sold out of Core Scientific, Inc. Common Stock (CORZ) in Q1 2023, closing a stake of 1,773 shares — an estimated $133 sold.

McIlrath & Eck first reported a position in CORZ in Q2 2022 and held it in 3 quarters. The position peaked at $3K in Q2 2022. 10 funds tracked by Wall St. Rank hold CORZ as of Q1 2023.

McIlrath & Eck reported no remaining Core Scientific, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
McIlrath & Eck sold 1,773 Core Scientific, Inc. Common Stock shares in Q1 2023, an estimated $133.
McIlrath & Eck first reported a position in Core Scientific, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
McIlrath & Eck's Core Scientific, Inc. Common Stock position peaked at $3K in Q2 2022.
10 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q1 2023.

Based on McIlrath & Eck's 13F filing for Q1 2023, filed 9 May 2023.